Philippe Dro Joins Adjuvant Capital as Partner
Biopharma and Medical Device Entrepreneur Joins to Strengthen Global Health Investment Team and Establish a Formal Presence in Europe
News provided by
Share this article
NEW YORK, April 29, 2021 /PRNewswire/
Adjuvant Capital, a life science investment firm focused on global health, today announced that Phillipe Dro, Pharm. D., MBA, will join as a partner and be based in Zurich, Switzerland. As a seasoned biopharma and medical device entrepreneur and executive with more than 25 years of experience, Dr. Dro brings significant operational, scientific, technical and product development expertise to the Adjuvant Capital team. He is currently chairman of the Board of Amsterdam-based Scenic Biotech, as well as Swiss companies, Luciole Medical and LimmaTech Biologics.
Philippe Dro Joins Adjuvant Capital as Partner apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.